Guidant News

The Santa Clara ophthalmic device company named Mark Murray chief financial officer.

John Lechleiter is so new to Eli Lilly and Co.'s top job that he's still traveling around the globe to meet employees.

The rating applies to approximately $13.9 billion of unsecured securities and commercial paper.

Global ophthalmic company OptiMedica Corp. has named Mark A. Murray its chief financial officer, a newly created position.

Belgian brewer InBev on Monday announced its latest move in its quest to buy Anheuser-Busch, putting up an alternative slate of directors that includes a member of the founding Busch family.

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration has approved the PROMUS Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease.

BOSTON Boston Scientific has agreed to sell pieces of its investment portfolio through two transactions that will raise a total of $140 million before taxes and help pay off debt, but also will force the ...

That's the message from Santa Clara County Assessor Larry Stone, who suspects that nine local companies - including the local offices of real estate development giant Trammell Crow and investment advisory ...

Our innovative technologies have saved and improved millions of lives. Guidant works diligently to create the most reliable products and services, enhance patient outcomes and limit adverse events to patients." ...

Nationwide class-action law firm Scott+Scott LLP announced today that the plaintiffs and former shareholders of Guidant Corporation ) in the In re: Guidant Corporation Securities Litigation , pending in the ... via LawFuel.com

“This was a great place to live”

A small Boston company that's working on a new type of stent will move its headquarters to the Triangle, where its new chief executive officer lives. via News Observer

For publication opinions today : In Thelma M. Nornes v. Raymond M. Nornes , a 6-page opinion, Judge Kirsch writes: Thelma M. Nornes appeals the trial court's Decree of Dissolution claiming that the trial court ... via Indiana Law Blog

Patients who received a faulty pacemaker have a few more days to get in on a $16 million settlement. via WSMV-TV Nashville

INDIANAPOLIS Guidant Corp., the Indianapolis-based medical-device maker acquired by Boston Scientific Corp. via IndyStar.com

Boston Scientific Corp. may now be free of what could have been a costly holdover from its $27 billion acquisition of Guidant Corp. via Boston Business Journal

Indianapolis A federal judge in Indianapolis has dismissed a shareholder complaint against Guidant Corp.'s former board of directors, ruling that the plaintiffs had no standing to sue as a result of the merger ... via IndyStar.com

A federal judge has dismissed a class-action lawsuit alleging that Guidant executives made misleading statements about the former company's pacemaker and defibrillator during its then-pending merger with ... via IndyStar.com

“They're going to give us a great view into what the future holds for the medical technology industry and what it will take to get there.”

Two early leaders of the nation's medical device industry and an experienced industry investment banker will headline the Council for Entrepreneurial Development's MedTech 2008 on March 6, 2008. via Customer Interaction Solutions